Valuation : AstraZeneca PLC

Market Cap 251B 217B 204B 186B 347B 23,710B 350B 2,415B 937B 12,122B 942B 922B 39,820B P/E 2026 *
20.8x
P/E 2027 * 18.2x
Enterprise Value 270B 233B 220B 200B 374B 25,535B 377B 2,601B 1,009B 13,055B 1,015B 993B 42,887B EV / Sales 2026 *
4.27x
EV / Sales 2027 * 3.93x
Free-Float
96.63%
Yield 2026 *
2.06%
Yield 2027 * 2.2%
1 day+0.32%
1 week-2.11%
Current month+0.05%
1 month+4.14%
3 months-9.37%
6 months-21.48%
Current year-13.15%
1 week 11,650
Extreme 11650
12,236
1 month 11,404
Extreme 11404
12,476
Current year 10,524
Extreme 10524
15,732
1 year 10,524
Extreme 10524
15,732
3 years 9,461
Extreme 9461
15,732
5 years 8,029
Extreme 8029
15,732
10 years 3,996
Extreme 3996
15,732
Manager TitleAgeSince
Chief Executive Officer 66 01/10/2012
Director of Finance/CFO 52 01/08/2021
Compliance Officer - 01/01/2023
Director TitleAgeSince
Director/Board Member 70 06/04/1999
Director/Board Member 66 01/10/2012
Director/Board Member 65 27/04/2017
Date Insider Type Main position Quantity % Market Cap. Importance
8/17/26 A Exercice

Chief Financial Officer

11,133 0.0007%
8/6/26 A Free

SVP, Group Controller

2 0.0000% -
7/6/26 A Free

See Remarks

2 0.0000% -
Change 5-day change 1-year change 3-year change Capi.($)
+0.12%-2.11%+0.60%+12.03% 251B
+0.23%-2.21%+58.21%+108.38% 1,034B
+1.17%+1.64%+54.12%+70.79% 654B
+0.25%-0.92%+22.91%+78.28% 459B
+0.49%-5.19%+33.28%+35.53% 343B
+0.27%+3.26%+29.76%+47.50% 307B
+0.46%+0.01%+53.49%+73.37% 237B
+2.64%-1.08%-15.85%-53.97% 202B
-0.38%+1.09%+32.82%+99.18% 186B
+1.66%+2.53%+16.15%-17.99% 163B
Average +0.69%-2.60%+28.55%+45.31% 383.43B
Weighted average by Cap. +0.58%-3.18%+37.81%+64.17%

Financials

2026 *2027 *
Net sales 63.24B 54.56B 51.39B 46.82B 87.52B 5,974B 88.18B 608B 236B 3,054B 237B 232B 10,033B 66.82B 57.64B 54.3B 49.48B 92.48B 6,312B 93.17B 643B 250B 3,227B 251B 245B 10,601B
Net income 12.02B 10.37B 9.77B 8.9B 16.64B 1,136B 16.76B 116B 44.89B 581B 45.14B 44.16B 1,907B 13.61B 11.74B 11.06B 10.08B 18.84B 1,286B 18.98B 131B 50.82B 657B 51.11B 49.99B 2,159B
Net Debt 19.33B 16.67B 15.71B 14.31B 26.75B 1,826B 26.95B 186B 72.16B 933B 72.57B 70.98B 3,066B 11.65B 10.05B 9.47B 8.63B 16.13B 1,101B 16.25B 112B 43.51B 563B 43.75B 42.8B 1,849B
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
02/09/26 GBX 11,976.00 +0.12% 1,946,304
01/09/26 GBX 11,962.00 -0.07% 2,914,975
28/08/26 GBX 11,970.00 -1.19% 3,627,957
27/08/26 GBX 12,114.00 -0.98% 3,580,853
26/08/26 GBX 12,234.00 -1.94% 2,784,068
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
161.82USD
Average target price
212.68USD
Spread / Average Target
+31.43%

Quarterly revenue - Rate of surprise